GRACEcast Lung Cancer Audio
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
- Update frequency
- every 7 days
- Average duration
- 15 minutes
- Episodes
- 136
- Years Active
- 2009 - 2013
Q and A Session with Drs. Ben Solomon and Ross Camidge on ALK Inhibition for Advanced NSCLC (audio)
Drs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NS…
ALK Inhibition: Who to Screen, and Additional Options for ALK-Positive Patients, by Dr. Ross Camidge (audio)
Dr. Ross Camidge reviews considerations of who to screen for an ALK rearrangement and additional treatment alternatives for patients with ALK-positive advanced non-small cell lung cancer.
ALK Inhibition: Science and Early Clinical Experience, by Dr. Ben Solomon (audio)
Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients …
Q and A Session with Dr. Rogerio Lilenbaum, on Managing Lung Cancer in Elderly Patients (audio)
Dr. Rogerio Lilenbaum, lung cancer expert, medical oncologist, & Chairman of Cleveland Clinic Florida, answers questions on special management considerations for elderly and frail patients with lung …
Challenges and Special Considerations in Treating Elderly and Poor Risk Patients with Lung Cancer, with Dr. Rogerio Lilenbaum (audio)
Dr. Rogerio Lilenbaum, medical oncologist and Chair of Heme/Onc at Cleveland Clinic in Weston, FL, reviews evidence on how age and other medical problems should be incorporated into management of lun…
Q and A Session with Dr. Mario Lacouture, on Skin, Hair, and Nail Care Issues in Cancer Patients (audio)
Dr. Mario Lacouture, expert dermatologist at Memorial Sloan-Kettering Cancer Center in NYC, answers questions on management of side effects related to skin, hair, and nails for patients on cancer tr…
Challenging Cases in Lung Cancer: Unresectable Locally Advanced NSCLC (audio)
Case-based discussion with multiple lung cancer experts on the controversial question of whether to recommend consolidation chemotherapy after concurrent chemotherapy and radiation for locally advanc…
ASCO 2011 Highlights: Q and A with Drs. Mary Pinder-Schenk and Nasser Hanna (audio)
Question and answer session with Drs. Mary Pinder-Schenck from Moffitt Cancer Center in Tampa and Nasser Hanna from Indiana University about highlights in lung cancer from ASCO 2011 annual meeting.
ASCO 2011 Highlights: Advanced/Metastatic Non-Small Cell Lung Cancer (audio)
Dr. Nasser Hanna from Indiana University Cancer Center reviews highlights of presentations on advanced/metastatic NSCLC from the ASCO 2011 annual meeting.
ASCO 2011 Highlights: SCLC, Early Stage NSCLC and Mesothelioma (audio)
Dr. Mary Pinder-Schenck from the H. Lee Moffitt Cancer Center in Tampa, FL reviews highlights of presentations on small cell lung cancer, early stage non-small cell lung cancer, and mesothelioma from…
Challenging Cases in Lung Cancer: Stage IIIA N2 Node-Positive NSCLC (audio)
Case-based discussion with multiple lung cancer experts on the optimal treatment of a patient with multi-station N2 node-positive squamous cell NSCLC, including whether surgery should be pursued.
Challenging Cases in Lung Cancer: Adjuvant Therapy for a Patient with a Smaller Node-Negative NSCLC Tumor (audio)
Case-based discussion with multiple lung cancer experts on whether to recommend post-operative (adjuvant) chemotherapy for a patient with a less than 4 cm non-small cell lung cancer (NSCLC) tumor wit…
Challenging Cases in Lung Cancer: Adjuvant Therapy for Small NSCLC Lesion with Satellite Nodules (audio)
Case-based discussion with multiple lung cancer experts on whether to recommend post-operative (adjuvant) chemotherapy for a patient with small non-small cell lung cancer (NSCLC) tumor with satellite…
Q and A with Dr. Minesh Mehta on Prevention and Treatment of Brain Metastases in Lung Cancer (audio)
Question and answer session with Dr. Minesh Mehta, Professor of Radiation Oncology at Northwestern University, on topics related to treatments for brain metastases and related complications, especial…
Dr. Minesh Mehta on Prevention and Treatment of Brain Metastases in Lung Cancer (audio)
Dr. Minesh Mehta, Professor of Radiation Oncology at Northwestern University, describes benefits and risks of multiple interventions that are currently used or being studied to reduce risk of develop…
Dr. Sequist, Q and A Session following Presentation on Acquired EGFR TKI Resistance and Data from Re-Biopsying Tumors (audio)
Dr. Lecia Sequist of Massachusetts General Hospital answers questions about acquired resistance to EGFR tyrosine kinase inhibitors and repeat biopsies of tumors over the course of treatment for advan…
Dr. Lecia Sequist on Results from Re-Biopsying Lung Cancer Lesions Over the Course of Treatment (audio)
Dr. Lecia Sequist of Massachusetts General Hospital describes the results of their experience in repeating biopsies in patients over the course of their ongoing treatment for advanced NSCLC and the c…
Dr. Lecia Sequist on Acquired Resistance to EGFR Tyrosine Kinase Inhibitors (audio)
Dr. Lecia Sequist of Massachusetts General Hospital presents a summary of the challenge of acquired resistance to EGFR tyrosine kinase inhibitors like Tarceva (erlotinib) and Iressa (gefitinib), alon…
Expert Round Table with Drs. Hensing and Jackman on Molecular Markers and Sequencing of Therapy for Advanced NSCLC, Case 3 (audio)
Case discussion with Drs. Tom Hensing of in Chicago & David Jackman in Boston, discussing practical issues around molecular marker testing & recommended treatments for first line & maintenance therap…
Expert Round Table with Drs. Hensing and Jackman on Molecular Markers and Sequencing of Therapy for Advanced NSCLC, Case 2 (audio)
Case discussion with Drs. Tom Hensing of in Chicago and David Jackman in Boston, discussing practical issues around molecular marker testing and recommended treatments for first line and maintenance …